Podcast

Implementing a Shingles Protocol in Primary Care Settings

Launch Date
09/29/2020
Credit Amount
0.00 Expired
Credit Expires
09/29/2021

Faculty

William Schaffner, MD
Professor of Preventive Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN
William Schaffner, MD

Dr. William Schaffner is Professor of Preventive Medicine in the Department of Health Policy and Professor of Infectious Diseases at the Vanderbilt University School of Medicine, Nashville, Tennessee.

Dr. Schaffner’s primary focus has been the prevention of infectious diseases. He is a strong proponent of collaboration between academic medical centers and public health institutions. He has worked extensively on the effective use of vaccines and has been a member of expert advisory committees that establish national vaccine policy.

Dr. Schaffner is committed to the communication of disease prevention with the general public and regards this as a teaching opportunity. He is often invited to comment on communicable disease issues on local and national media, translating research and public health events into language that the public can understand.

After graduating from Yale in 1957, Schaffner attended the University of Freiburg, Germany as a Fulbright Scholar. He graduated from Cornell University Medical College in 1962 and completed residency training and a Fellowship in Infectious Diseases at Vanderbilt. He was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention (CDC) for two years. He returned to Vanderbilt after that tour of duty and established a long collaboration with the Tennessee Department of Health and the CDC.

Iris Gorfinkel, MD, CM
Founder and Principal Investigator, PrimeHealth Clinical Research, Toronto, ON
Iris Gorfinkel, MD, CM

Iris Gorfinkel, MD, CM, is a family physician and Founder/Principal Investigator of PrimeHealth Clinical Research. She has participated in over 60 clinical trials and has a special interest in vaccination research. She helped co-author seminal papers on Shingrix and sat as a co-chair on the Shingrix Advisory Board. Additionally, Dr. Gorfinkel is active in-patient advocacy and produces a regular medical radio column on CBC Radio One.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

An estimated 1 million people get shingles each year, with about 1 in 10 developing postherpetic neuralgia that lasts months or years, and 1% – 4% being hospitalized for complications. Despite the availability of a shingles vaccine, about only 1 in 3 eligible adults ≥ 60 years old and just 37% of adults ≥ 65 years old have been vaccinated. Clinicians should recognize the risk factors for shingles (e.g., increasing age, decline in cell-mediated immunity, gender, race, chronic disease, etc.) and take proactive measures in promoting vaccination. Primary care settings are ideal for identifying appropriate patients for shingles vaccination, as well as discussing shingles and shingles vaccination. However, barriers to implementing a shingles protocol may exist.

The first episode of this CMEOCast podcast series focuses on reinforcing the importance of vaccination against shingles, improving vaccination uptake in ethnic minorities and at-risk patients, and developing best practices to implement a shingles protocol in primary care settings.

Learning Objectives

At the end of this CME/CE activity, participants should be able to develop best practices to implement a shingles protocol in primary care settings.

The following learning objectives pertain only to those requesting CNE or CPE credit: Describe best practices for a shingles protocol in primary care settings.

Financial Support

This educational activity is supported by an educational grant from GlaxoSmithKline.

Target Audience

Physicians, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-132-H06-P

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Schaffner has no disclosures to report.

Dr. Gorfinkel reports that she receives research support from GlaxoSmithKline and Merck & Co., Inc. She is on the advisory committee and a consultant for GlaxoSmithKline.

  • Tony Graham, MD (peer reviewer) has no disclosures to report.
  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
  • Kashemi Rorie, PhD (planning committee) has no disclosures to report.
  • Evan Luberger (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.
  • Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-132-H06-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

PD-028-092920-06

Implementing a Shingles Protocol in Primary Care Settings
Event Date: 09/29/2020